Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kidswell Bio Corporation ( (JP:4584) ) just unveiled an announcement.
Kidswell Bio Corporation, along with Alfresa Holdings, Chiome Bioscience, and Mycenax Biotech, has agreed to establish a joint venture to develop a domestic manufacturing facility for biosimilars under a subsidy program by Japan’s Ministry of Health, Labour and Welfare. This initiative aims to enhance domestic supply capabilities, support the export of biosimilars, and foster the development of skilled professionals, thereby advancing Japan’s biopharmaceutical industry.
The most recent analyst rating on (JP:4584) stock is a Hold with a Yen249.00 price target. To see the full list of analyst forecasts on Kidswell Bio Corporation stock, see the JP:4584 Stock Forecast page.
More about Kidswell Bio Corporation
Kidswell Bio Corporation is involved in the biosimilars industry, focusing on creating a comprehensive healthcare system for children, families, and society. It promotes its biosimilars business as a stable earnings base.
Average Trading Volume: 2,102,259
Technical Sentiment Signal: Hold
Current Market Cap: Yen12.04B
For detailed information about 4584 stock, go to TipRanks’ Stock Analysis page.